Feedback / Questions
Radspherin - Oncoinvent
https://www.oncoinvent.com/press-release/oncoinvent-asa-announces-positive-safety-review-of-lead-in-cohort-advances-to-randomised-part-of-ongoing-phase-2-trial-of-radspherin-in-ovarian-cancer-patients/
Mar 25, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next